Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Burn Injuries01:22

Burn Injuries

2.4K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
2.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

469
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
469
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

5.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.6K
Introduction to Hemostasis01:05

Introduction to Hemostasis

5.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are Routine Labs Necessary? Postoperative Electrolyte Trends in Lipedema Patients Undergoing Liposuction: Insights from a Single-Center Retrospective Cohort.

Aesthetic plastic surgery·2026
Same author

Authors' Response to "Vasopressors in Early Burn Resuscitation: Physiological Concerns Revisited".

Acta anaesthesiologica Scandinavica·2026
Same author

Performance of Sepsis-3 criteria in burn patients: A multicenter real-world study.

Burns : journal of the International Society for Burn Injuries·2026
Same author

Impact of Hypothyroidism on Short-Term and Long-Term Outcomes of Coronary Artery Bypass Graft Surgery.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Risk of Malignancy with Immunosuppressive Drugs Used in Organ Transplants Compared to Those Used for Non-Transplant Indications.

Cancers·2026
Same author

Utilising Single Cell Analysis and Spatial Transcriptomics to Elucidate Molecular Mechanisms of Wound Healing: A Literature Review.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2026
Same journal

Challenges in Antimicrobial Treatment and Antimicrobial Stewardship in Hospital-Acquired Infections in Adult Burn Patients.

European burn journal·2026
Same journal

Bridging the Evidence-Practice Gap in Early Burn Injury Care: A Comprehensive Evidence Synthesis of Global Guidelines, Consensus, and Systematic Reviews for Resource-Limited Settings.

European burn journal·2026
Same journal

Automated Classification of Second- and Third-Degree Burn Images Using Convolutional Neural Networks.

European burn journal·2026
Same journal

A Single-Centre Review of Outcomes of Delayed Admission to a Burns Unit.

European burn journal·2026
Same journal

Simulation Enhances Resident Preparedness Using Skin Cell Suspension Autograft.

European burn journal·2026
Same journal

The 4th Educational Course of the European Burns Association (EBA).

European burn journal·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes
02:49

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes

Published on: February 23, 2024

1.0K

Nonsteroidal Anti-Inflammatory Drugs Decrease Coagulopathy Incidence in Severe Burn Patients.

Lyndon Huang1, Kassandra Corona1, Kendall Wermine1

  • 1School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.

European Burn Journal
|November 27, 2024
PubMed
Summary
This summary is machine-generated.

Nonsteroidal anti-inflammatory drugs (NSAIDs) significantly reduced coagulopathy, sepsis, and mortality in severely burned patients. Early NSAID use offers protective benefits during the acute phase of burn injury.

Keywords:
TriNetX databaseinternational normalized ratio (INR)mortalityretrospective studysepsis

More Related Videos

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
07:45

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment

Published on: November 6, 2018

9.7K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

241

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes
02:49

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes

Published on: February 23, 2024

1.0K
Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
07:45

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment

Published on: November 6, 2018

9.7K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

241

Area of Science:

  • Trauma Surgery
  • Pharmacology
  • Critical Care Medicine

Background:

  • Burn-induced coagulopathy is a severe complication impacting patient outcomes.
  • Early intervention strategies are crucial for managing severe burn injuries.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) have potential anti-inflammatory and analgesic properties.

Purpose of the Study:

  • To investigate the impact of early nonsteroidal anti-inflammatory drug (NSAID) administration on burn-induced coagulopathy.
  • To assess the effect of NSAIDs on mortality and sepsis development in severely burned patients.
  • To determine the protective role of NSAIDs during the acute phase of severe burns.

Main Methods:

  • Retrospective cohort study using the TriNetX research network.
  • Identification of severely burned patients (TBSA > 20%) receiving NSAIDs within the first week post-burn.
  • Statistical analysis comparing coagulopathy, sepsis, and mortality rates between NSAID and non-NSAID groups after matching.

Main Results:

  • NSAID use was associated with a significant reduction in burn-induced coagulopathy (17.7% vs. 32.3%, p < 0.0001).
  • Patients receiving NSAIDs showed significantly lower rates of sepsis (p < 0.01) and mortality (p < 0.0001).
  • NSAID group also demonstrated a significant decrease in thrombocytopenia (p < 0.001).

Conclusions:

  • Early administration of NSAIDs demonstrates significant protective effects in severely burned patients.
  • NSAIDs reduce the risk of burn-induced coagulopathy, sepsis, and mortality in the acute phase.
  • NSAIDs represent a potential therapeutic option for improving outcomes in severe burn management.